Clinical Trial Update: Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA) [Phase 3]

View source ↗

Summary

A Phase 3 trial of MRA for systemic juvenile idiopathic arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Juvenile Idiopathic Arthritis

Drugs mentioned

• MRA (MRA)

Snippet

Sponsor: Chugai Pharmaceutical | Conditions: Systemic Juvenile Idiopathic Arthritis | Phase 3 | Status: COMPLETED